Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current Assets
Cash and cash equivalents	$ 8,053,879	$ 10,931,890
Short-term investments	88,324,922	100,842,438
Accounts receivable	66,049	177,239
Prepaid expenses and other current assets	2,886,520	1,842,620
Total Current Assets	99,331,370	113,794,187
Property and Equipment, net	2,158,479	676,262
Other Assets.
In-process R&D	3,500,000	5,866,000
Goodwill		1,452,338
Grant receivable	1,318,359
Operating lease right-of-use asset	1,782,884	2,035,882
Finance lease right-of-use asset	470,700	247,194
Other assets	12,193,540
Deposits	205,901	122,779
Total Other Assets	19,471,384	9,724,193
Total Assets	120,961,233	124,194,642
Current Liabilities
Accounts payable	922,782	1,051,764
Deferred revenue, current portion		603,717
Operating lease liability, current portion	350,343	278,753
Finance lease liability, current portion	260,574	108,127
Accrued expenses and other liabilities	2,419,676	1,614,534
Contingent consideration, current portion	593,037
Contingent consideration, related party - current portion	174,333
Total Current Liabilities	4,720,745	3,656,895
Long Term Liabilities
Other long-term liabilities	53,530	36,243
Derivative warrant liability	11,020	33,779
Deferred tax liability	215,937	361,911
Deferred revenue, net of current portion	35,000	237,500
Operating lease liability, net of current portion	1,060,856	1,301,636
Financing lease liability, net of current portion	255,429	160,240
Contingent consideration	1,990,118	2,250,844
Contingent consideration, related party	585,027	661,671
Total Liabilities	8,927,662	8,700,719
Commitments and Contingencies
Stockholders' Equity
Common stock, $.0002 par value; 250,000,000 and 250,000,000 shares authorized, 25,279,624 and 22,592,500 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively	5,055	4,519
Additional paid-in capital	278,890,153	247,048,349
Accumulated deficit	(165,718,953)	(130,647,485)
Accumulated other comprehensive loss	(67,941)	(166,056)
Total Stockholders' Equity - Heat Biologics, Inc.	113,108,314	116,239,327
Non-Controlling Interest	(1,074,743)	(745,404)
Total Stockholders' Equity	112,033,571	115,493,923
Total Liabilities and Stockholders' Equity	$ 120,961,233	$ 124,194,642